Insulet (PODD) Surpasses Q2 Earnings and Revenue Estimates

Insulet (PODD) came out with quarterly earnings of $1.17 per share, beating the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $0.55 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of +25.81%. A quarter ago, it was expected that this maker of insulin infusion systems would post earnings of $0.81 per share when it actually produced earnings of $1.02, delivering a surprise of +25.93%. Over the last four ...